U ncorrected refractive error is the leading cause of visual impairment throughout the world.
lying stromal surface, was the first of these techniques described. [4] [5] [6] However, because it is a surface ablation procedure, PRK has limitations such as postoperative pain, delayed epithelial healing, and anterior stromal haze development. 7, 8 As such, PRK declined in popularity with the introduction and development of intrastromal ablative techniques such as laser in situ keratomileusis (LASIK). [9] [10] [11] However, surface ablation procedures such as PRK retain certain advantages over LASIK, such as inflicting less corneal biomechanical insult and avoiding both intraoperative and late flaprelated complications. [12] [13] [14] Therefore, during the past two decades, other surface ablation procedures have been developed to try to overcome some of the limitations of PRK while retaining its advantages. These procedures include transepithelial photorefractive keratectomy (T-PRK), laser epithelial keratomileusis (LASEK), 15 and epithelial LASIK (epi-LASIK). 16, 17 A fundamental difference between the various surface ablative techniques is the method of epithelial removal. Alcohol or mechanical debridement has been advocated for the preservation of the epithelium as a flap, as in LASEK and epi-LASIK, respectively. 18 This flap can then be placed over the ablated stromal surface to reduce postoperative pain and speed epithelial healing time. Alternatively, epithelial removal can be undertaken by the laser itself as in T-PRK. This technique has several perceived advantages, including no instrument contact with the cornea, reduced intervention time, and the potential to minimize the size of the epithelial defect required for stromal ablation, as well as the avoidance of alcohol and potential toxicity as in LASEK. 19 Although these new approaches to surface laser ablation offer apparent theoretical improvements over traditional PRK, they each have different advantages and disadvantages. What is currently lacking is a comprehensive evidence-based approach to determine the relative merits of each of these procedures over each other and PRK.
Although several conventional pairwise metaanalyses of the four surface refractive ablation procedures (PRK, LASEK, epi-LASIK, and T-PRK) have been published, [20] [21] [22] [23] these publications share several limitations. First, they are unable to provide clear hierarchies for these four available treatments due to a lack of head-to-head comparisons. Second, some previous analyses included non-randomized controlled trials that might influence the quality of the evidence. However, a network meta-analysis can combine direct evidence from individual trials and indirect evidence gleaned using statistical techniques across trials, enabling simultaneous "all-way" comparisons of multiple interventions. 24 This technique is therefore particularly suitable to address questions relating to the relative safety and benefits of different treatment modalities for a single condition. We therefore performed this network meta-analysis of available randomized controlled trials (RCTs) to systematically compare the efficacy, predictability, safety, postoperative haze, pain scores, and epithelial healing time of the four major surface ablative procedures described above and to provide evidence-based rankings of these treatments.
METHODS
This systematic review complies with the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) network meta-analysis extension statement. 25 
OutcOme measurements
Efficacy (uncorrected distance visual acuity [UDVA] of 20/20 or better), predictability (refractive spherical equivalent [SE] within ±0.50 diopters [D] of the target), and safety (loss of two or more lines of spectacle corrected distance visual acuity [CDVA]) were set as primary outcome measures. Haze, pain scores, and epithelial healing time were set as secondary outcome measures. Pain data were assessed using a 10-point scale at days 1 and 3 postoperatively. When data at day 3 were not available, the outcome at the follow-up time point closest to day 3, such as day 2 or day 4, was used. The results of efficacy, predictability, safety, and haze were analyzed at 6 months postoperatively. When data at 6 months were not available, the outcome at the follow-up time point closest to 6 months was used.
eligibility criteria
Trials were included if they met the following criteria: (1) treated population: patients with myopia; (2) interventions: PRK, T-PRK, LASEK, or epi-LASIK; (3) comparisons: two or more laser corneal surface ablation techniques (as listed above); (4) at least one of the following outcomes: efficacy, safety, predictability, postoperative haze, pain, and epithelial healing time; and (5) study design: RCTs. We excluded trials if they contained only one of the surface ablation techniques, did not use randomization for treatment allocation, used mitomycin C (MMC) during surgery, or if participants were followed up for less than 3 months after surgery. MMC was not included due to the controversial nature of the use of this drug.
search methOds
A systematic literature review was conducted using PubMed, Embase, The Cochrane Library, and the U.S. trial registry (www.ClinicalTrial.gov) for RCTs published up to June 2018 without language restrictions. The full search strategies are shown in Table A (available in the online version of this article). We also manually examined the reference lists of clinical trials, related meta-analyses, and systematic reviews to identify relevant studies.
study selectiOn
Screening was performed by two independent investigators (YH, BS). They retrieved the full-text articles that appeared relevant after reviewing the titles and abstracts and independently assessed them for final eligibility. Any discrepancies were resolved by focused discussion or consultation with an additional investigator (RT).
data extractiOn and risk Of bias assessment
Two investigators independently extracted information into an electronic database, including the participant and intervention characteristics, outcomes, and quantitative results for treatment effects. For data that were missing or could not be directly obtained, we contacted the authors of trial reports or used GetData GraphDigitizer 2.24 (http://getdata-graph-digitizer.com) to read data from figures.
To appraise the study quality, the Cochrane Collaboration risk-of-bias method was used. 26 In this method, we graded all reports at low, high, or unclear risk of bias for each of the following items: random sequence generation and allocation concealment (both items relate to selection bias), masking of participants and personnel (detection bias), incomplete outcome data (attrition bias), selective reporting (reporting bias), and other biases. Two investigators also independently assessed the quality of the body of evidence for outcomes within the network meta-analysis according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) method as very low, low, moderate, or high. 27 The GRADE considered the following domains: study limitations, indirectness, inconsistency, imprecision of effect estimates, and risk of reporting bias.
data analysis
We first conducted traditional pairwise meta-analyses for direct comparisons using random-effects models. For binary outcomes, relative effect sizes were calculated as odds ratios (ORs) with 95% confidence intervals (CIs). For continuous outcomes, relative effect sizes were calculated as weighted mean differences (WMDs) with 95% CI. For positive outcomes (ie, efficacy and predictability, where a greater value indicates a better result), an OR of greater than 1 or WMD of greater than 0 corresponded to beneficial treatment effects of the first treatment compared with the second treatment. When the outcomes were negative (ie, safety, haze, pain, or epithelial healing time, where a greater value indicates a worse result), an OR of less than 1 or WMD of less than 0 corresponded to beneficial treatment effects of the first treatment compared with the second treatment. We used visual inspection of the forest plots and the I 2 statistic 28 (values of 50% or more indicated substantial heterogeneity) to investigate the possibility of statistical heterogeneity. We used STATA software (version 12.0; StataCorp LP, College Station, TX) for statistical analyses.
To incorporate indirect comparisons, we performed Bayesian random-effects network meta-analyses using Markov chain Monte Carlo methods in GeMTC GUI 0.14.3 29 to estimate pooled ORs and WMD with 95% credible intervals (CrI). We used four parallel chains and obtained 50,000 samples after a 20,000-sample burn-in in each chain. To check convergence, we used the Gelman and Rubin diagnostic 30 and trace plots. We ranked treatments based on the analysis of ranking probabilities and the surface under the cumulative ranking curve (SUCRA). 31 The SUCRA values, expressed as a percentage, showed the relative probability of an intervention being the best option. Inconsistency between direct and indirect evidence was assessed by a "node-splitting" approach. 32 When high heterogeneity or inconsistency was found, a "leaveone-out procedure" in which each trial is left out, one at a time, was done for further sensitivity analyses. Funnel plots were used to evaluate publication bias in the results between small and large studies.
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RESULTS
study selectiOn
Figure A (available in the online version of this article) shows the detailed steps of the study selection process. The literature search yielded 608 potentially relevant studies (the detailed search strategy is shown in Table A ). Of these, 36 potentially eligible studies were retrieved from the electronic databases and 5 additional studies were located from the references of selected studies, making a total of 41. After excluding 23 studies on the basis of the predefined inclusion criteria, 18 studies were included in the network metaanalysis. study characteristics and netwOrk geOmetry A summary of all eligible studies is shown in 
Quality Of the evidence
The quality of the studies included in the network meta-analysis is shown in Table C-1 (Quality of the Included Trials) and Table C-2 (Analysis by Synthesis) (available in the online version of this article). In relation to the complete outcome data, almost 25% of trials were rated as "high risk of bias" (4 trials, 22.2%), but most were rated as "low risk of bias" (11 trials, 61.1%). Those rated as "unclear risk of bias" reported allocation concealment and masking of outcome assessment (14 and 12 trials, respectively). The results of the GRADE are shown in Table C-3 (available in the online version of this article). Across the outcomes of the network meta-analysis, we found 8 comparisons (15.7% of all comparisons) of high quality, 28 (54.9%) of moderate quality, and 15 (29.4%) of low quality. The comparisons were all assessed as moderate-high quality for efficacy, predictability, safety, and pain scores on day 3, and low-moderate for haze, pain scores on day 1, and epithelial healing time. For most of the outcomes, the main issues that reduced confidence in estimates were risk of bias and imprecision.
results Of meta-analysis Direct Comparisons. Table 1 shows the results of efficacy, predictability, and safety based on direct comparisons. Ten articles reported the percentage of eyes with UDVA of 20/20 or better postoperatively (defined as efficacy). The results show that there was no statistically significant difference between the four major types of corneal surface ablation laser refractive surgery and high heterogeneity for all comparisons. Predictability was measured by the proportion of eyes where the postoperative refractive error was within ±0.50 D of the target refraction. We found that 8 studies had sufficient data for this analysis. Statistical analyses of these data showed no statistically significant effect of the type of corneal surface ablation laser refractive surgery. The proportion of eyes with a loss of two or more lines of CDVA was used as a measure of safety. This parameter was reported in 6 studies. The results show that there was no statistically significant difference between the types of corneal surface ablation laser refractive surgery and high heterogeneity for all comparisons (I 2 < 50%). Tables 2-3 show the results of postoperative haze, pain scores, and epithelial healing time based on direct comparisons. Six trials reported haze scores. We found one statistically significant difference between LASEK and PRK (WMD = -0.19, 95% CI = -0.37 to -0.01), whereas high heterogeneity was observed between LASEK and PRK (I 2 = 88.9%) (forest plots in Table D , available in the online version of this article). We also analyzed the data at two different grades (grade 0.5 or higher and grade 1.0 or higher) in 7 trials; no statistically significant difference between the types of corneal surface ablation laser refractive surgery was found and high heterogeneity was found for both grades (I 2 < 50%). Six studies reported postoperative pain scores. We analyzed the postoperative pain scores at days 1 and 3. Statistically significant differences were found between PRK and T-PRK at day 1 (WMD = 1.24, 95% CI = 1.00 to 1.48), LASEK and T-PRK at day 1 (WMD = -1.23, 95% CI = -2.10 to -0.36), PRK and epi-LASIK at day 3 (WMD = -2.16, 95% CI = -3.55 to -0.77), and PRK and T-PRK at day 3 (WMD = 0.48, 95% CI = 0.23 to 0.73). There was no high heterogeneity for all comparisons (I 2 < 50%). Twelve studies reported epithelial healing time. A statistically significant difference was found between PRK and T-PRK (WMD = 1.57, 95% CI = 1.33 to 1.75). We also found high heterogeneity between PRK and epi-LASIK (I 2 = 91.4%), PRK and LASEK (I 2 = 97.1%), and LASEK and epi-LASIK (I 2 = 76.6%) (forest plots are shown in Table D) .
Combination of Direct and Indirect Comparisons. Figure C (available in the online version of this article) shows the results of efficacy, predictability, and safety based on Bayesian network meta-analyses that combine direct and indirect comparisons. The ranking probabilities for all procedures are presented in Table E (available in the online version of this article), along with the ranking probabilities of other results. For the primary outcomes, there were no statistically significant differences in any comparison in terms of efficacy, safety, and predictability (P > .05). For the ranking results, LASEK came first in efficacy, predictability, and safety on the SUCRA values (Figure 1) . The results for postoperative haze based on Bayesian network meta-analyses are shown in Figure D (available in the online version of this article). There was no statistically significant difference between any of the studied techniques (P > .05). For haze scores, epi-LASIK had the least haze as per the SUCRA values. T-PRK ranked first in haze scores at grade 0.5 or higher, whereas epi-LASIK ranked first with haze scores at grade 1 or higher (Figure 2) . The results for pain scores and epithelial healing time can be seen in Figure E (available in the online version of this article). As shown, statistically significant differences only exist when epi-LASIK was compared with PRK (WMD = 2.17, 95% CrI = 0.19 to 4.01) and T-PRK (WMD = 2.69, 95% CrI = 0.51 to 4.84) in terms of pain scores on day 3. LASEK ranked highest for pain on day 1 and T-PRK had the least pain on day 3. T-PRK ranked first in terms of epithelial healing time (Figure 3) .
Inconsistency. Node-splitting analysis between LASEK, PRK, and T-PRK for closed-loop comparisons in terms of pain score on day 1 shows significant inconsistency (P = .05). However, for other results comparisons between direct and indirect estimates did not suggest significant inconsistency between direct and indirect evidence (Table F, available in the online version of this article, P value varying from .22 to .99).
Sensitivity Analysis. For further sensitivity analyses, we undertook a "leave-one-out procedure" in which each trial is left out, one at a time (full process and data shown in Table G , available in the online version of this article). This process produced no significant change in the results.
For the postoperative haze scores in direct comparison of LASEK and PRK (WMD = -0.19, 95% CrI = -0.37 to -0.01, I 2 = 88.9%), there was a statistically significant difference. When removing any single article, I 2 values were all still greater than 65% and the result turned to no statistically significant difference except when removing Ghanem et al. 35 (WMD = -0.25, 95% CrI = -0.44 to -0.07, I 2 = 84.8%). For pain score on day 1, no statistically significant difference between any of the studied techniques was found when removing any study.
For epithelial healing time, high heterogeneity was found. This heterogeneity remained even after removing the two largest contributors, which prevented any meaningful sensitivity analysis for this outcome. This variability indicates the need for cautious interpretation of our data on epithelial healing time.
Publication Bias. Comparison-adjusted funnel plots for each outcome including all primary outcomes and secondary outcomes are provided in Table H (available in the online version of this article). Most of these plots show that the included studies lie symmetrically around the 0 line (vertical line); we did not find evidence of a small-study effect or significant publication bias in the network.
DISCUSSION
This study provides an in-depth statistical comparison of the four major excimer laser corneal surface ablation refractive procedures: PRK, T-PRK, LASEK, and epi-LASIK, for correcting myopia, combining data from 18 trials and 1,399 eyes. In addition to efficacy, predictability, and safety, it also considers a wide range of clinically relevant outcomes including postoperative pain, haze, and epithelial healing time. The variety of available surface ablation techniques and the lack of large definitive trials with multiple treatment arms make a network meta-analysis particularly useful in this field. According to GRADE, the quality of outcomes within this network meta-analysis was mostly evaluated as moderate or high (70.6%), which indicated an acceptable level of evidence.
The main conclusion of our network meta-analysis is the confirmation 36 that all surface laser refractive technologies included in this analysis have excellent efficacy, predictability, and safety, at least in the short term (6 months after surgery). For many of the outcomes analyzed, no statistically significant differences were found (ie, in relation to efficacy, predictability, safety, postoperative haze, day 1 pain score, and epithelial healing time) (Tables 1-3 ). However, in terms of pain score on day 3, epi-LASIK was significantly more painful compared to PRK and T-PRK ( Table 3) .
In addition to determining the statistical differences of specific outcomes between procedures, our analysis (using SUCRA) provides a numerical ranking of all procedures for each outcome. SUCRA values show the relative probability of an intervention being the best option, providing an estimate of the relative dominance of the treatment in the absence of significant differences in statistical analysis. LASEK demonstrates relative advantages in three visual outcomes (efficacy, predictability, and safety) compared with the other techniques assessed, but results in greater postoperative corneal haze. Epi-LASIK demonstrates better haze scores while performing less well in relation to postoperative comfort (pain score and epithelial healing time). T-PRK tops the rankings in relation to postoperative haze grade 0.5 or higher, pain scores, and epithelial healing time, whereas PRK fails to achieve top ranking in any of the studied outcomes.
Efficacy, predictability, and safety are the most important outcomes in evaluations of corneal refractive surgery. 37, 38 There are several trials and meta-analyses that compare the direct evidence for these three outcomes between different surface laser procedures. In 2010, Zhao et al. 20 performed a meta-analysis to examine possible differences in efficacy and predictability between LASEK and PRK. They indicated that LASEK had no significant benefits over PRK in terms of efficacy (OR = 0.86, 95% CI = 0.61 to 1.20) or predictability (OR = 0.90, 95% CI = 0.63 to 1.29). Wu et al. 21 compared epi-LASIK and PRK in relation to efficacy and predictability, reporting no statistically significant differences in either efficacy (relative risk = 1.43, 95% CI = 0.85 to 2.40) or predictability (relative risk = 1.03, 95% CI = 0.92 to 1.16). These findings are similar to our results, although we also found no statistically significant difference in safety when PRK was compared with either epi-LASIK or LASEK. However, we found that LASEK demonstrated relative advantages in these three outcomes in terms of ranking and that PRK ranks lowest for both predictability and safety.
Postoperative haze formation is an important factor that may directly influence the efficacy, safety, and visual quality of corneal refractive surgery. Zhao et al. 20 contrasted LASEK and PRK in terms of corneal haze, reporting that no statistically significant difference was observed between the LASEK-treated groups and PRKtreated groups at 6 months after surgery (WMD = 0.14, 95% CI = -0.02 to 0.30), which was similar to our results ( Table 2) . We found that epi-LASIK and T-PRK performed best on SUCRA ranking in terms of haze. These findings may be associated with the release of transforming growth factor (TGF)-1. The researchers found TGF-1 is released into the tear film by the lacrimal gland after corneal epithelial injury and TGF-1 levels correlated positively with the degree of haze, whereas tear fluid TGF-1 levels were less following epi-LASIK than after LASEK. 39, 40 As previously mentioned, high heterogeneity was found in direct comparison of LASEK and PRK, and we could not identify a particular study as the source of high heterogeneity through sensitivity analysis. We propose that the variability between studies may be attributed to the relatively small sample size and the subjective nature of assessing haze.
41,42
Postoperative pain and epithelial healing time are two important factors that influence patient preference for a specific procedure. In 2002, Litwak et al. 43 reported that LASEK induced more pain than standard PRK. However, in our study, the results showed that there was no statistically significant difference between PRK and LASEK, and the SUCRA ranking showed that PRK was more likely to cause pain than LASEK at 1 day postoperatively. These differences may be attributable to the devitalized flap in LASEK, or it may be the result of the release of chemical factors such as prostaglandin, histamine, and substance P by corneal tissue. 44 Interestingly, our study found that epi-LASIK resulted in more pronounced pain compared to PRK and T-PRK at day 3 postoperatively. This might be due to delayed epithelial wound healing; Hondur et al. 45 reported slightly longer epithelial healing time with epi-LASIK compared to LASEK.
However, in relation to epithelial healing time, our statistical results indicate that heterogeneity is too high to draw reliable conclusions. Differing postoperative topical drug regimens and the variable use of bandage contact lenses may influence postoperative epithelial healing time and could have contributed to this high heterogeneity.
In terms of our study limitations, the difference between the internal characteristics of research and studies based on the small sample sizes can be the key factors that influence both heterogeneity in direct comparisons and transitivity in indirect comparison. 46, 47 For our study, although there are some differences in characteristics among the included studies (eg, the race of the study population, the choice of laser device, and the type or frequency of postoperative medication), factors that may have a potential impact on results were reasonably consistent (eg, mean dioptric correction [range: -6.32 to -2.04 D] and mean age [range: 23 to 35.7 years]). There were only two trials involving T-PRK, and with such paucity of data we should be cautious with the interpretation of the results involving T-PRK. We chose the follow-up time point closest to 6 months postoperatively to analyze outcomes for some studies because of the lack of data after 6 months postoperatively.
It is important to note that our findings are only applicable to the treatment of myopia without the use of MMC. Additional evaluation of the comparative safety and effectiveness of corneal surface laser refractive surgery with and without MMC is warranted.
Although a range of outcomes was assessed in this study, higher order aberrations, contrast sensitivity, and patient-reported outcomes such as subjective quality of vision 48, 49 were not included due to a lack of data in the form of RCTs. This meta-analysis was also specifically designed to compare different corneal surface ablation techniques rather than excimer laser ablation profiles.
This network meta-analysis demonstrates that the four major corneal surface laser refractive surgeries for the correction of myopia are comparable in efficacy, predictability, safety, postoperative haze, and comfort, with the exception of pain score on day 3. Epi-LASIK was significantly more painful compared to PRK and T-PRK on postoperative day 3. Table A Search Strategy 
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